Quick Overview: Big data is accelerating progress in neurodegenerative and rare diseases. In this webinar, Amy Easton (VP of In a recent interview, Matthew Disney, Ph.D., Institute Professor at The Wertheim UF Scripps Institute for Biomedical Innovation ... In a world of incredible scientific advancements, it seems inconceivable that it has been more than 150 years since
Advancing Research With Target Als - Detailed Overview & Context
Big data is accelerating progress in neurodegenerative and rare diseases. In this webinar, Amy Easton (VP of In a recent interview, Matthew Disney, Ph.D., Institute Professor at The Wertheim UF Scripps Institute for Biomedical Innovation ... In a world of incredible scientific advancements, it seems inconceivable that it has been more than 150 years since It was a pleasure to sit down with Jenna Gregory, Ph.D., Senior Clinical Lecturer and Associate Professor at the University of ... It was a pleasure to sit down with Dr. Dorothy Schafer, Associate Professor of Neurobiology, University of Massachusetts Chan ... What is needed to discover effective ALS treatments?
We sat down with Atalanta Therapeutics Vice President and Head of Neuroscience, Dr. Stefan McDonough to discuss his ... We sat down with Rebecca Luker Courage Award Winner, Merit Cudkowicz, Ph.D. to discuss the current state of In our latest video, Dr. Jonathan Cooper-Knock, Clinician Scientist at The University of Sheffield, shares details of his In early 2023, Ernie Ruiz noticed he couldn't run like he used to. At first, he thought he was just out of shape. But when he had a ... Don't miss our interview with Senior Director of Scientific Initiatives at The Association for Frontotemporal Degeneration (AFTD), ...
